investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Clinical and Tissue Core

Nikhil C Munshi

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

No posts

Related projects

Ratneshwar Lal

Amyloid ion channels to design therapeutics for neurodegenerative diseases

Multiple myeloma and immunoproliferative diseases

Pathology

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Wendy Cozen

Genome Wide Admixture Scan for Multiple Myeloma in African Americans

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Steven M Lipkin

Whole Genome Sequencing to Discover Familial Myeloma Risk Genes

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Kenneth C Anderson

Specialized Program of Research Excellence (SPORE) in Multple Myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Integrative Oncogenomics of Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Genomic Analysis to Gain Insights into Novel and Clinically Relevant Mol

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Sign Up For Updates

Stay up to date with what's going on with The GO Map.